GlaxoSmithKline (Jobs) Quits Early Biovitrum AB Obesity Drug Project
LONDON, June 5 (Reuters) - GlaxoSmithKline Plc has abandoned an early stage project to develop a new kind of anti-obesity drug with Biovitrum AB, the Swedish biotech company said on Tuesday.